Your institution may have access to this item. Find your institution then sign in to continue.
Title
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
Authors
Kindler, H. L.; Richards, D. A.; Garbo, L. E.; Garon, E. B.; Stephenson, J. J.; Rocha-Lima, C. M.; Safran, H.; Chan, D.; Kocs, D. M.; Galimi, F.; McGreivy, J.; Bray, S. L.; Hei, Y.; Feigal, E. G.; Loh, E.; Fuchs, C. S.